Novartis's Piqray Gets Europe Green Light At Last

First-In-Class PI3K inhibitor Approved For Breast Cancer

 
• By Kevin Grogan
  
Approved
Piqray finally gets seal of approval in Europe • Source: Shutterstock

More from New Products

More from Scrip